Bristol Myers Squibb is a global biopharmaceutical company whose mission is to uncover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Inequities in healthcare systems present a unique global challenge, with some studies suggesting SDoH factors account for up to 50% of health outcomes within the United States. The grantees were selected in countries with underserved communities living with cancer and blood disorders.